SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals

The use of statins as the preferred lipid-lowering therapy has clearly demonstrated its efficacy in the treatment of hypercholesterolemia, reducing also the risk of coronary events and cardiovascular disease mortality. In this study, we assessed single nucleotide polymorphisms (SNPs) in the SLCO1B1...

Descripción completa

Detalles Bibliográficos
Autores principales: Prado, Yalena, Saavedra, Nicolás, Zambrano, Tomás, Lagos, Jenny, Rosales, Alexy, Salazar, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613221/
https://www.ncbi.nlm.nih.gov/pubmed/26334272
http://dx.doi.org/10.3390/ijms160920609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613221/
https://www.ncbi.nlm.nih.gov/pubmed/26334272
http://dx.doi.org/10.3390/ijms160920609

Ejemplares similares